Compared with placebo, secukinumab demonstrated superior pain reduction in moderate to severe hidradenitis suppurativa in two phase 3 trials. Improvements in pain were sustained through week 52 and ...
The results of an interventional trial presented today at the European League Against Rheumatism Annual Congress (EULAR 2015) showed that use of the disease-modifying anti-rheumatic drug ...
Everyday Health on MSN
7 best medical and therapeutic interventions for acute pain
Top strategies from experts on how to get acute pain relief.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results